Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31842
Title: Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
Austin Authors: Chandrasekara, S;Lau, E M;Anderson, J;Collins, N;Cordina, R;Corrigan, C;Dwyer, N;Feenstra, J;Horrigan, Mark ;Keogh, A;Kotlyar, E;Lavender, M;McWilliams, T;Rhodes, B;Steele, P;Strange, G;Thakkar, V;Weintraub, R;Whitford, H;Whyte, K;Williams, T ;Wrobel, J;Keating, D T
Affiliation: School of Medicine, University of Notre Dame, Fremantle, WA, Australia.
Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.
School of Medicine, University of Notre Dame, Fremantle, WA, Australia
Pulmonary Hypertension Society of Australia and New Zealand.
Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia
Department of Rheumatology, Liverpool Hospital, Sydney, NSW, Australia.
Royal Children's Hospital, Melbourne, Vic, Australia
Murdoch Children's Research Institute, Melbourne, Vic, Australia
University of Melbourne, Melbourne, Vic, Australia.
Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia
Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Respiratory Department, Sunshine Coast University Hospital, Birtinya, Qld, Australia.
Department of Cardiology, John Hunter Hospital, Newcastle, NSW, Australia.
Department of Cardiology, Royal Prince Alfred Hospital, and Heart Research Institute, Sydney, NSW, Australia.
Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.
Department of Cardiology, Royal Hobart Hospital, Hobart, Tas, Australia.
Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Qld, Australia.
Austin Health
Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.
Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.
Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia.
Greenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand.
Department of Respiratory Medicine, Christchurch Hospital, Christchurch, New Zealand.
Department of Cardiovascular Services, Royal Adelaide Hospital, Adelaide, SA, Australia.
Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.
Greenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand.
Department of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.
Issue Date: 8-Feb-2023
Date: 2022
Publication information: Heart, Lung and Circulation (2023) 32, 156–165
Abstract: Pulmonary arterial hypertension (PAH) has a progressive, unremitting clinical course. Vasoreactivity testing (VdT) during right heart catheterisation (RHC) identifies a subgroup with excellent long-term response to calcium channel blockade (CCB). Reporting on these patients is limited. Established in 2011, the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry offers the opportunity to assess the frequency of VdT during RHC, treatment and follow up of PAH patients.
URI: https://ahro.austin.org.au/austinjspui/handle/1/31842
DOI: 10.1016/j.hlc.2022.09.005
ORCID: 
Journal: Heart, Lung & Circulation
PubMed URL: 36503731
ISSN: 1444-2892
Type: Journal Article
Subjects: Calcium channel blockers
Pulmonary hypertension
Right heart catheter
Right ventricular failure
Vasoreactivity testing
Appears in Collections:Journal articles

Show full item record

Page view(s)

36
checked on Jul 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.